Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers

Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials